Status:
COMPLETED
An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial
Lead Sponsor:
Terry Fox Foundation
Collaborating Sponsors:
Tata Memorial Hospital
Conditions:
Sarcoma
Eligibility:
All Genders
1-65 years
Brief Summary
The purpose of this study is to evaluate the impact on overall survival of an intensive follow-up protocol (as practiced today at TMH) against a more cost effective follow-up protocol in patients oper...
Detailed Description
Follow up studies are performed for a variety of reasons. The detection of a recurrence of the index lesion is the foundation of surveillance. Detection of other medical conditions is a secondary bene...
Eligibility Criteria
Inclusion
- Patients operated for primary or recurrent extremity bone \& soft tissue sarcomas.(both limb salvage and amputations)
- Non Metastatic at presentation.
- Patients reliable for follow-up.
Exclusion
- Non-extremity sarcomas.
- Metastatic at presentation
- Patients unreliable for follow up.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2015
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00384735
Start Date
January 1 2006
End Date
December 31 2015
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012